Oncology Medical News about Anthracyclines

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era
The Oncologist, 10/28/09

Robson D et al. – Molecular predictors, such as human epidermal growth factor receptor 2 and topoisomerase IIalpha , are further refining the optimal role of anthracyclines. With these new advances, the current role of anthracycline–based chemotherapy in early–stage breast cancer demands re–examination.

<< Previous
Cytopathologist-performed ultrasound-guided fine-needle...

Next >>
Resection of the Primary Colorectal Cancer Is Not Necessary in...